R156-17b-618. Change in Ownership or Location

  (1) In accordance with Section 58-17b-614, except for changes in ownership caused by a change in the stockholders in corporations that are publicly listed and whose stock is publicly traded, a licensed pharmaceutical facility shall make application for a new license and receive approval from the Division no later than ten business days prior to any of the following proposed changes:

  (a) location or address, except for a reassignment of a new address by the United States Postal Service that does not involve any change of location;

  (b) name, except for a doing-business-as (DBA) name change that is properly registered with the Division of Corporations and filed with the Division of Occupational and Professional Licensing; or

  (c) ownership when one of the following occurs:

  (i) a change in entity type; or

  (ii) the sale or transfer of 51% or more of an entity's ownership or membership interest to another individual or entity.

  (2) Upon approval of the change in location, name, or ownership, and the issuance of a new license, the original license shall be surrendered to the Division.

  (3) Upon approval of the name change, the original licenses shall be surrendered to the Division.